Having COVID-19 pneumonia vs. non-COVID-19 pneumonia while receiving extracorporeal membrane oxygenation negatively impacted ...

A new study reveals differences in survival rates for COVID-19 pneumonia patients treated with ECMO compared to non-COVID-19 pneumonia patients.

The UAB Extracorporeal Membrane Oxygenation (ECMO) Program aims to staff multiple patients in need of ECMO treatment in a dedicated section of the cardiothoracic ICU with full support of an ECMO ...

VOV.VN - Nearly 200 domestic and international experts are sharing experience in deploying the extracorporeal membrane ...

Technological advancements in treatment options, such as percutaneous ventricular assist devices (pVADs) and extracorporeal membrane oxygenation (ECMO), are ... Older adults are more likely ...

Gohibic also has an FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalized adults when initiated within 48 hours of receiving IMV or ECMO.